Cargando…
Facing the reality of drug-resistant tuberculosis in India : challenges and potential solutions : summary of a joint workshop /
"An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a majority of TB cases, resistance to these antibiotics has emerged over the years, resulting in...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores Corporativos: | , , |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
National Academies Press,
©2012.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn812066702 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 120516s2012 dcuab ob f100 0 eng d | ||
| 010 | |a 2012554874 | ||
| 040 | |a CDX |b eng |e pn |c CDX |d OCLCO |d N$T |d NTE |d YDXCP |d OCLCA |d OCLCQ |d OCLCO |d EBLCP |d OCLCO |d OCLCQ |d VT2 |d OCLCQ |d OCLCO |d AGLDB |d DXU |d MERUC |d OCLCO |d OCLCQ |d OCLCA |d ZCU |d OCLCO |d OCLCA |d U3W |d OCLCO |d OCLCA |d KIJ |d OCLCF |d VNS |d OCLCO |d VTS |d OCLCA |d ICG |d OCLCQ |d LVT |d YOU |d S9I |d STF |d DKC |d OCLCO |d OCLCQ |d M8D |d OCLCQ |d OCLCA |d UKAHL |d OCLCA |d AJS |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCL |d OCLCQ | ||
| 016 | 7 | |a 101592314 |2 DNLM | |
| 016 | 7 | |a 016165983 |2 Uk | |
| 019 | |a 923289220 |a 971070319 |a 1021249774 |a 1021257866 |a 1028810873 |a 1048175607 |a 1055339460 |a 1061052627 |a 1061073440 |a 1119446056 |a 1119508575 |a 1156351898 |a 1204390040 |a 1204392905 |a 1228538413 |a 1249239121 | ||
| 020 | |a 9780309219679 |q (electronic bk.) | ||
| 020 | |a 0309219671 |q (electronic bk.) | ||
| 020 | |z 9780309219662 |q (pbk.) | ||
| 020 | |z 0309219663 |q (pbk.) | ||
| 024 | 8 | |a 9786613948922 | |
| 029 | 1 | |a AU@ |b 000051431109 | |
| 029 | 1 | |a DEBBG |b BV042796173 | |
| 029 | 1 | |a DEBBG |b BV044109421 | |
| 029 | 1 | |a DEBSZ |b 421364688 | |
| 029 | 1 | |a GBVCP |b 804119031 | |
| 035 | |a (OCoLC)812066702 |z (OCoLC)923289220 |z (OCoLC)971070319 |z (OCoLC)1021249774 |z (OCoLC)1021257866 |z (OCoLC)1028810873 |z (OCoLC)1048175607 |z (OCoLC)1055339460 |z (OCoLC)1061052627 |z (OCoLC)1061073440 |z (OCoLC)1119446056 |z (OCoLC)1119508575 |z (OCoLC)1156351898 |z (OCoLC)1204390040 |z (OCoLC)1204392905 |z (OCoLC)1228538413 |z (OCoLC)1249239121 | ||
| 043 | |a a-ii--- | ||
| 050 | 4 | |a RC311.1 |b .F33 2012eb | |
| 060 | 4 | |a WF 200 | |
| 072 | 7 | |a MED |x 062000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.995 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Facing the reality of drug-resistant tuberculosis in India : |b challenges and potential solutions : summary of a joint workshop / |c by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research ; Steve Olson [and others], rapporteurs ; Forum on Drug Discovery, Development, and Translation ; Board on Health Sciences Policy ; Institute of Medicine of the National Academies. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c ©2012. | ||
| 300 | |a 1 online resource (xix, 165 pages) : |b illustrations (some color), color maps | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 504 | |a Includes bibliographical references (pages 121-128). | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a FrontMatter -- Reviewers -- Contents -- Tables, Figures, and Boxes -- Acronyms -- 1 Introduction -- 2 Drug-Resistant TB in India -- 3 The Global Burden of Drug-Resistant TB -- 4 Preventing Transmission of Drug-Resistant TB -- 5 Detecting Drug Resistance and Strengthening Laboratory Capacity -- 6 Addressing TB and Drug-Resistant TB in Vulnerable Populations -- 7 Combating Drug-Resistant TB Through Public�Private Collaboration and Innovative Approaches -- 8 Confronting Challenges to the Supply Chain for Second�Line Drugs -- 9 Creating a Blueprint for Action | |
| 520 | |a "An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a majority of TB cases, resistance to these antibiotics has emerged over the years, resulting in the growing spread of multidrug-resistant (MDR) TB. Due to challenges in timely and accurate diagnosis of drug-resistant TB, length and tolerability of treatment regimens, and expense of second-line anti-TB drugs, effectively controlling the disease requires complex public health interventions. The IOM Forum on Drug Discovery, Development, and Translation held three international workshops to gather information from local experts around the world on the threat of drug resistant TB and how the challenges it presents can be met. Workshops were held in South Africa and Russia in 2010. The third workshop was held April 18-19, 2011, in New Delhi, India, in collaboration with the Indian National Science Academy and the Indian Council of Medical Research. The aim of the workshop was to highlight key challenges to controlling the spread of drug-resistant strains of TB in India and to discuss strategies for advancing and integrating local and international efforts to prevent and treat drug-resistant TB. This document summarizes the workshop."--Publisher's description. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Multidrug-resistant tuberculosis |z India |x Prevention |v Congresses. | |
| 650 | 0 | |a Tuberculosis |z India |v Congresses. | |
| 650 | 0 | |a Drug resistance |v Congresses. | |
| 650 | 0 | |a Multidrug-resistant tuberculosis. | |
| 650 | 0 | |a Antitubercular agents. | |
| 650 | 0 | |a Tuberculosis. | |
| 650 | 1 | 2 | |a Tuberculosis, Multidrug-Resistant |
| 650 | 2 | 2 | |a Antitubercular Agents |
| 650 | 2 | 2 | |a Tuberculosis |
| 651 | 2 | |a India | |
| 650 | 6 | |a Tuberculose |z Inde |v Congrès. | |
| 650 | 6 | |a Résistance aux médicaments |v Congrès. | |
| 650 | 6 | |a Tuberculose multirésistante. | |
| 650 | 6 | |a Antituberculeux. | |
| 650 | 6 | |a Tuberculose. | |
| 650 | 7 | |a MEDICAL |x Oncology. |2 bisacsh | |
| 650 | 7 | |a Multidrug-resistant tuberculosis |2 fast | |
| 650 | 7 | |a Antitubercular agents |2 fast | |
| 650 | 7 | |a Drug resistance |2 fast | |
| 650 | 7 | |a Tuberculosis |2 fast | |
| 651 | 7 | |a India |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJmdx47cDXrRhBXHtbvPwC | |
| 655 | 2 | |a Congress | |
| 655 | 7 | |a proceedings (reports) |2 aat | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a Olson, Steve, |d 1956- |1 https://id.oclc.org/worldcat/entity/E39PBJpV6yX9jFKMQMYFvVkhpP | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Drug Discovery, Development, and Translation. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Indian National Science Academy. | |
| 710 | 2 | |a Indian Council of Medical Research. | |
| 758 | |i has work: |a Facing the reality of drug-resistant tuberculosis in India (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGBGWch3QG4ckFYDp7qHfq |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Facing the reality of drug-resistant tuberculosis in India. |d Washington, D.C. : National Academies Press, ©2012 |z 9780309219662 |w (OCoLC)793806636 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378993 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36559672 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36617472 | ||
| 938 | |a Coutts Information Services |b COUT |n 23606268 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL3378993 | ||
| 938 | |a EBSCOhost |b EBSC |n 476040 | ||
| 938 | |a YBP Library Services |b YANK |n 9596125 | ||
| 994 | |a 92 |b IZTAP | ||